Utility of the cutaneous silent period in patients with diabetes mellitus JOURNAL OF THE NEUROLOGICAL SCIENCES Kim, B., Kim, N., Kim, S. G., Roh, H., Park, H., Park, M., Park, K., Cho, S. C., So, Y. T. 2010; 293 (1-2): 1-5


We performed this study to evaluate whether or not the cutaneous silent period (CSP) is a useful metric to identify small-fiber neuropathy in diabetic patients. The CSP was measured from the abductor pollicis brevis muscle in 30 healthy controls and 110 diabetic patients, who in turn were divided into 3 subgroups (patients with large-fiber neuropathy, patients with small-fiber neuropathy, and asymptomatic patients). The measured CSP and clinical characteristics were compared among the groups. The power of the CSP in discriminating patients from controls and any correlation with other clinical variables were analyzed. Each patient subgroup had a significantly delayed CSP latency compared to the controls. The latency of patients with large-fiber neuropathy was also significantly prolonged compared to the other subgroups of patients. The CSP latency was the only variable to discriminate patients. The latency showed a significant correlation with the late responses in nerve conduction studies. Thus, the CSP latency may be a useful tool in evaluating small neural fiber function in diabetic patients.

View details for DOI 10.1016/j.jns.2010.03.032

View details for Web of Science ID 000278652500001

View details for PubMedID 20417526